Drawing based on the label description. No photo yet.
5 mg BP 667 pill
Pill with imprint 5 mg BP 667 is red, capsule, 14 mm and has been identified as Tacrolimus Capsules 5 mg. It is supplied by Belcher Pharmaceuticals,llc.
Tacrolimus Capsules 5 mg
- Imprint
- 5 mg BP 667
- Strength
- 5 mg
- Color
- Red
- Shape
- Capsule / oblong
- Size
- 14 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Belcher Pharmaceuticals,llc
- NDC
- 62250-667, 62250-667-02
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Tacrolimus Capsules used for?
Official uses from the US prescribing label
Prophylaxis of Organ Rejection in Kidney Transplant
Tacrolimus Capsules is indicated for the prophylaxis of organ rejection in patients receiving allogeneic kidney transplants. It is recommended that tacrolimus be used concomitantly with azathioprine or mycophenolate mofetil (MMF) and adrenal corticosteroids. Therapeutic drug monitoring is recommended for all patients receiving tacrolimus.
Prophylaxis of Organ Rejection in Liver Transplant
Tacrolimus Capsules is indicated for the prophylaxis of organ rejection in patients receiving allogeneic liver transplants. It is recommended that tacrolimus be used concomitantly with adrenal corticosteroids. Therapeutic drug monitoring is recommended for all patients receiving tacrolimus.
Prophylaxis of Organ Rejection in Heart Transplant
Tacrolimus Capsules is indicated for the prophylaxis of organ rejection in patients receiving allogeneic heart transplants. It is recommended that tacrolimus capsules be used concomitantly with azathioprine or mycophenolate mofetil (MMF) and adrenal corticosteroids. Therapeutic drug monitoring is recommended for all patients receiving tacrolimus capsules.
Limitations of Use
Tacrolimus Capsules should not be used simultaneously with cyclosporine.
Use with sirolimus is not recommended in liver and heart transplant. The safety and efficacy of tacrolimus with sirolimus has not been established in kidney transplant.
Intravenous use reserved for patients who cannot tolerate capsules orally.
From the FDA-approved label on DailyMed (published Oct 06, 2023).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows 5 mg BP 667. The parts can be split between the two sides, so turn the pill over and check both.
- It is red, capsule, 14 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Sold under the brand name Tacrolimus.
Ingredients
Active: Tacrolimus
Inactive: Anhydrous Lactose, Hypromellose 2208 (100 Mpa.s), Croscarmellose Sodium, Magnesium Stearate, Gelatin, Titanium Dioxide, Ferric Oxide Red, Shellac, Dimethicone, Hydrated Silica
Other pills with imprint 5 mg BP 667
Same imprint, different listing. Check the color, size and maker against your pill.
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
G 687
Tacrolimus 5 mg
Red, capsule, 14 mm
Used for eczema
-
B30
Cyclobenzaprine Hydrochloride 30 mg
Blue & red, capsule, 14 mm
Used for muscle stiffness (spasticity) and muscle spasms
-
LA 43
Pregabalin 75 mg
Red & white, capsule, 14 mm
Used for seizures and nerve pain after shingles
Schedule V
-
5MG RDY527
Tacrolimus 5 mg
Red, capsule, 14 mm
Used for eczema
-
R 069
Oxazepam 15 mg
Red, capsule, 14 mm
Used for anxiety and focal seizures
Schedule IV
- Cipla 03050mg Nilotinib 50 mg Red, capsule, 15 mm Used for accelerated phase myeloid leukemia and chronic-phase myeloid leukemia